Abbonarsi

Acantholytic squamous cell carcinoma is usually associated with hair follicles, not acantholytic actinic keratosis, and is not “high risk”: Diagnosis, management, and clinical outcomes in a series of 115 cases - 18/04/17

Doi : 10.1016/j.jaad.2016.09.024 
Toru Ogawa, MD, PhD a, Maija Kiuru, MD, PhD a, b, Thomas H. Konia, MD a, b, Maxwell A. Fung, MD a, b, ⁎
a Department of Dermatology, University of California Davis, Sacramento, California 
b Department of Pathology and Laboratory Medicine, University of California Davis, Sacramento, California 

∗Correspondence to: Maxwell A. Fung, MD, Department of Dermatology, University of California Davis, 3301 C St, Suite 1400, Sacramento, CA 95816.Department of DermatologyUniversity of California Davis3301 C St, Suite 1400SacramentoCA95816

Abstract

Background

Acantholytic squamous cell carcinoma (aSCC) is regarded as a high-risk variant of cutaneous squamous cell carcinoma (SCC). Acantholytic actinic keratosis (aAK) has been regarded as a precursor risk factor for aSCC. However, supporting evidence is limited.

Objective

We sought to document clinical features, histologic features, management, and outcomes in a series of aSCC cases.

Methods

Definitions of aSCC, aAK, and aSCC arising in association with aAK were applied to a consecutive series of aSCC cases. Clinical characteristics and outcomes were obtained from electronic medical records.

Results

Of 115 aSCC cases (103 patients, mean age 71.8 years), actinic keratosis was present in 23% (27/115) but only 7.8% (9/115) exhibited associated aAK. Ten cases (10/115, 9%) fulfilled strict histologic criteria for follicular SCC as previously defined, but 50 of 115 (43%) of our aSCC cases exhibited predominant involvement of follicular epithelium rather than epidermis. Clinical outcome (median follow-up, 36 months) was available in 106 of 115 (92%). One patient experienced regional extension (parotid), and 1 patient experienced a local recurrence (nose). No disease-related metastases or deaths were documented.

Limitations

This was a single-institution retrospective study from the United States.

Conclusions

The presence of acantholysis in cutaneous SCC does not specifically confer aggressive behavior, a finding that may inform clinical practice guidelines.

Il testo completo di questo articolo è disponibile in PDF.

Key words : acantholysis, acantholytic actinic keratosis, cutaneous oncology, dermatopathology, follicular squamous cell carcinoma, nonmelanoma skin cancer, outcomes, prognosis, squamous cell carcinoma

Abbreviations used : aAK, AK, aSCC, EORTC, KA, NCCN, SCC


Mappa


 Dr Kiuru's involvement in this research was in part supported by the National Cancer Institute, National Institutes of Health, through grant K12CA138464.
 Conflicts of interest: None declared.
 Reprints not available from the authors.


© 2016  American Academy of Dermatology, Inc.. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 76 - N° 2

P. 327-333 - febbraio 2017 Ritorno al numero
Articolo precedente Articolo precedente
  • Treatment of recalcitrant port-wine stains (PWS) using a combined pulsed dye laser (PDL) and radiofrequency (RF) energy device
  • Yoon-Soo Cindy Bae, Hamad Alabdulrazzaq, Jeremy A. Brauer, Roy G. Geronemus
| Articolo seguente Articolo seguente
  • Tumor necrosis factor-? inhibitor-induced psoriasis: Systematic review of clinical features, histopathological findings, and management experience
  • Gabrielle Brown, Eva Wang, Argentina Leon, Monica Huynh, Mackenzie Wehner, Rebecca Matro, Eleni Linos, Wilson Liao, Anna Haemel

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.